Global $45 Billion Endoscopy Market Insights & Forecasts to 2025

The “Global Endoscopy Market (by Product, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2021-2025)” report is available.

The global endoscopy market is predicted to reach US$45.28 billion in 2025, growing, at a CAGR of 7.50%, for the duration spanning 2021-2025.

The factors such as rising healthcare expenditure, growing occurrence of chronic diseases, rising obese population and increasing elderly population are expected to drive the market growth.

However, the market growth would be challenged by associated patient risk, dearth of skilled endoscopists & physicians and high cost of endoscopic procedures. A few notable trends may include upsurge in alcohol consumption, surging incidence of cancer cases, emergence of capsule endoscopy, new endoscopy product launch, advances in endoscopy and rising preference for minimally invasive procedures.

The global endoscopy market has been segmented on the basis of product, application and end-user. In terms of product, the global endoscopy market can be categorized into endoscopes, visualization systems, endoscopic ultrasound, insufflator and other. According to application, the endoscopy market can be segmented into gastrointestinal endoscopy, laparoscopy, urology endoscopy, arthroscopy and others. Whereas, the endoscopy market can be split into hospitals, ambulatory surgical centers (ASCs) and other end-users.

The fastest-growing regional market is North America due to rising burden of cancer, increasing favorable reimbursement scenario in the region, growing obese population, growing investments by hospitals to purchase new endoscopic equipment and increasing research and development activities to improve endoscopy.

However, the sudden outbreak of COVID-19 has caused an adverse disruption on global economy and society, affecting the rate of endoscopic procedures, which is negatively impacted the growth of the global endoscopy market in 2020.

Scope of the report

  • The report provides a comprehensive analysis of the global endoscopy market segmented on the basis of product, application, end-user and region.
  • The major regional markets (North America, Asia-Pacific, Europe Rest of the World) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Johnson & Johnson (Ethicon Endo-Surgery Inc.), Medtronic PLC, FUJIFILM Holdings Corporation, Boston Scientific Corporation, Olympus Corporation and Ambu A/S) are also presented in detail.

Key Topics Covered:

1. Market Overview
1.1 Introduction
1.2 Types of Wearables
1.3 Wearable Technology Application in Healthcare
1.4 Advantages of Wearable Technology in Fitness
1.5 The need for Wearables Technology

2. COVID-19 Impact
2.1 Endoscopy During the COVID-19 Pandemic
2.2 Downfall in Therapeutic Device Market
2.3 Decline in Colonoscopies
2.4 Impact on the Practice of Otorhinolaryngology

3. Global Market Analysis
3.1 Global Endoscopy Market by Value
3.2 Global Endoscopy Market Forecast by Value
3.3 Global Endoscopy Market by Product
3.4 Global Endoscopy Market by Application
3.5 Global Endoscopy Market by End-User
3.6 Global Endoscopy Market by Region

4. Regional Market Analysis
4.1 North America
4.2 Europe
4.3 Asia Pacific
4.4 ROW

5. Market Dynamics
5.1 Growth Drivers
5.1.1 Rising Healthcare Expenditure
5.1.2 Growing Occurrence of Chronic Diseases
5.1.3 Rising Obese Population
5.1.4 Increasing Elderly Population
5.2 Key Trends & Developments
5.2.1 Upsurge in Alcohol Consumption
5.2.2 Surging Incidence of Cancer Cases
5.2.3 Emergence of Capsule Endoscopy
5.2.4 New Endoscopy Products Launch
5.2.5 Advances in Endoscopy
5.2.6 Rising Preference for Minimally Invasive Procedures
5.3 Challenges
5.3.1 Associated Patient Risk
5.3.2 Dearth of Skilled Endoscopists & Physicians
5.3.3 High Cost of Endoscopic Procedures

6. Competitive Landscape
6.1 Global Market
6.1.1 Key Players – Revenue Comparison
6.1.2 Key Players – Market Capitalization Comparison
6.1.3 Key Players – R&D Comparison
6.1.4 Global Endoscope Market Share by Key Players
6.1.5 Global Single Use Endoscope Market Share by Key Players
6.1.6 Global Gastrointestinal (GI) Endoscopy Market Share by Company
6.1.7 Global Surgical Endoscopy Market Share by Company
6.2 Japan Market
6.2.1 Japan Gastrointestinal (GI) Endoscopy Instruments Market Share by Company
6.2.2 Japan Surgical Endoscopy Market Share by Company

7. Company Profiles
7.1 Business Overview
7.2 Financial Overview
7.3 Business Strategies

  • Ambu A/S
  • Olympus Corporation
  • Boston Scientific Corporation
  • FUJIFILM Holdings Corporation
  • Medtronic PLC
  • Johnson & Johnson (Ethicon Endo-Surgery Inc.)

For more information about this report visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”